Liver iron influences the response to interferon alpha therapy in chronic hepatitis C

Silvia Fargion, Anna Ludovica Fracanzani, Maurizio Sampietro, Virginio Molteni, Renzo Boldorini, Michela Mattioli, Bruno Cesana, Giovanna Lunghi, Alberto Piperno, Carla Valsecchi, Gemino Fiorelli

Research output: Contribution to journalArticle

Abstract

Objective: To define whether there is any relation between the iron status of patients with hepatitis C virus (HCV) chronic liver disease anti their response to interferon therapy. Design: To evaluate the long-term response to 1 year of interferon therapy with addition of phlebotomies after 3 months of treatment if at that time alanine aminotransferase (ALT) had not normalized in a group of patients with HCV-positive chronic liver disease whose iron status had been characterized. Setting: A northern Italian hospital. Participants: Fifty-eight anti-HCV-positive patients (four HCV-RNA negative) with biopsy proven chronic hepatitis and no evidence of iron overload as indicated by normal transferrin saturation at the time of enrolment in the study. Intervention: Three times a week intramuscular injection of alpha interferon 3 MU for 1 year with addition of phlebotomies (350 ml/week) till iron depletion if after 3 months of interferon therapy ALT had not normalized. Results: A long-term response was observed in 19 of the 52 patients who completed the treatment, four HCV-RNA negative and 15 positive. The four RNA-negative and seven of the 15 RNA-positive long-term responders had been treated with interferon alone, and the other eight also with phlebotomies. At univariate analysis only HCV genotype, gamma-glutamyltranspeptidase and liver iron concentration were significantly associated with response whereas sinusoidal iron deposition was of borderline significance. No association was found with sex, age, duration of disease, histology, Knodell score, transferrin saturation %, serum ferritin, hepatocytic iron score, and portal iron score. HCV-RNA serum levels, measured in 29 patients, did not correlate with response. At multivariate analysis liver iron concentration was still significant and one unit reduction of liver iron concentration (natural logarithm transformed) was associated with 2.95 odds ratio of response. Conclusion: These results indicate that iron in the liver is more closely related to response to interferon than the other variables considered, including HCV characteristics.

Original languageEnglish
Pages (from-to)497-503
Number of pages7
JournalEuropean Journal of Gastroenterology and Hepatology
Volume9
Issue number5
Publication statusPublished - 1997

Fingerprint

Chronic Hepatitis C
Interferon-alpha
Iron
Hepacivirus
Liver
Interferons
Phlebotomy
RNA
Therapeutics
Transferrin
Alanine Transaminase
Liver Diseases
Chronic Disease
Iron Overload
Intramuscular Injections
Chronic Hepatitis
Ferritins
Serum
Histology
Multivariate Analysis

Keywords

  • Cellular iron distribution
  • Chronic hepatitis C
  • Interferon
  • Liver iron concentration

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Liver iron influences the response to interferon alpha therapy in chronic hepatitis C. / Fargion, Silvia; Ludovica Fracanzani, Anna; Sampietro, Maurizio; Molteni, Virginio; Boldorini, Renzo; Mattioli, Michela; Cesana, Bruno; Lunghi, Giovanna; Piperno, Alberto; Valsecchi, Carla; Fiorelli, Gemino.

In: European Journal of Gastroenterology and Hepatology, Vol. 9, No. 5, 1997, p. 497-503.

Research output: Contribution to journalArticle

Fargion, S, Ludovica Fracanzani, A, Sampietro, M, Molteni, V, Boldorini, R, Mattioli, M, Cesana, B, Lunghi, G, Piperno, A, Valsecchi, C & Fiorelli, G 1997, 'Liver iron influences the response to interferon alpha therapy in chronic hepatitis C', European Journal of Gastroenterology and Hepatology, vol. 9, no. 5, pp. 497-503.
Fargion, Silvia ; Ludovica Fracanzani, Anna ; Sampietro, Maurizio ; Molteni, Virginio ; Boldorini, Renzo ; Mattioli, Michela ; Cesana, Bruno ; Lunghi, Giovanna ; Piperno, Alberto ; Valsecchi, Carla ; Fiorelli, Gemino. / Liver iron influences the response to interferon alpha therapy in chronic hepatitis C. In: European Journal of Gastroenterology and Hepatology. 1997 ; Vol. 9, No. 5. pp. 497-503.
@article{9f04952c7e964522bbbe70515b549265,
title = "Liver iron influences the response to interferon alpha therapy in chronic hepatitis C",
abstract = "Objective: To define whether there is any relation between the iron status of patients with hepatitis C virus (HCV) chronic liver disease anti their response to interferon therapy. Design: To evaluate the long-term response to 1 year of interferon therapy with addition of phlebotomies after 3 months of treatment if at that time alanine aminotransferase (ALT) had not normalized in a group of patients with HCV-positive chronic liver disease whose iron status had been characterized. Setting: A northern Italian hospital. Participants: Fifty-eight anti-HCV-positive patients (four HCV-RNA negative) with biopsy proven chronic hepatitis and no evidence of iron overload as indicated by normal transferrin saturation at the time of enrolment in the study. Intervention: Three times a week intramuscular injection of alpha interferon 3 MU for 1 year with addition of phlebotomies (350 ml/week) till iron depletion if after 3 months of interferon therapy ALT had not normalized. Results: A long-term response was observed in 19 of the 52 patients who completed the treatment, four HCV-RNA negative and 15 positive. The four RNA-negative and seven of the 15 RNA-positive long-term responders had been treated with interferon alone, and the other eight also with phlebotomies. At univariate analysis only HCV genotype, gamma-glutamyltranspeptidase and liver iron concentration were significantly associated with response whereas sinusoidal iron deposition was of borderline significance. No association was found with sex, age, duration of disease, histology, Knodell score, transferrin saturation {\%}, serum ferritin, hepatocytic iron score, and portal iron score. HCV-RNA serum levels, measured in 29 patients, did not correlate with response. At multivariate analysis liver iron concentration was still significant and one unit reduction of liver iron concentration (natural logarithm transformed) was associated with 2.95 odds ratio of response. Conclusion: These results indicate that iron in the liver is more closely related to response to interferon than the other variables considered, including HCV characteristics.",
keywords = "Cellular iron distribution, Chronic hepatitis C, Interferon, Liver iron concentration",
author = "Silvia Fargion and {Ludovica Fracanzani}, Anna and Maurizio Sampietro and Virginio Molteni and Renzo Boldorini and Michela Mattioli and Bruno Cesana and Giovanna Lunghi and Alberto Piperno and Carla Valsecchi and Gemino Fiorelli",
year = "1997",
language = "English",
volume = "9",
pages = "497--503",
journal = "European Journal of Gastroenterology and Hepatology",
issn = "0954-691X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Liver iron influences the response to interferon alpha therapy in chronic hepatitis C

AU - Fargion, Silvia

AU - Ludovica Fracanzani, Anna

AU - Sampietro, Maurizio

AU - Molteni, Virginio

AU - Boldorini, Renzo

AU - Mattioli, Michela

AU - Cesana, Bruno

AU - Lunghi, Giovanna

AU - Piperno, Alberto

AU - Valsecchi, Carla

AU - Fiorelli, Gemino

PY - 1997

Y1 - 1997

N2 - Objective: To define whether there is any relation between the iron status of patients with hepatitis C virus (HCV) chronic liver disease anti their response to interferon therapy. Design: To evaluate the long-term response to 1 year of interferon therapy with addition of phlebotomies after 3 months of treatment if at that time alanine aminotransferase (ALT) had not normalized in a group of patients with HCV-positive chronic liver disease whose iron status had been characterized. Setting: A northern Italian hospital. Participants: Fifty-eight anti-HCV-positive patients (four HCV-RNA negative) with biopsy proven chronic hepatitis and no evidence of iron overload as indicated by normal transferrin saturation at the time of enrolment in the study. Intervention: Three times a week intramuscular injection of alpha interferon 3 MU for 1 year with addition of phlebotomies (350 ml/week) till iron depletion if after 3 months of interferon therapy ALT had not normalized. Results: A long-term response was observed in 19 of the 52 patients who completed the treatment, four HCV-RNA negative and 15 positive. The four RNA-negative and seven of the 15 RNA-positive long-term responders had been treated with interferon alone, and the other eight also with phlebotomies. At univariate analysis only HCV genotype, gamma-glutamyltranspeptidase and liver iron concentration were significantly associated with response whereas sinusoidal iron deposition was of borderline significance. No association was found with sex, age, duration of disease, histology, Knodell score, transferrin saturation %, serum ferritin, hepatocytic iron score, and portal iron score. HCV-RNA serum levels, measured in 29 patients, did not correlate with response. At multivariate analysis liver iron concentration was still significant and one unit reduction of liver iron concentration (natural logarithm transformed) was associated with 2.95 odds ratio of response. Conclusion: These results indicate that iron in the liver is more closely related to response to interferon than the other variables considered, including HCV characteristics.

AB - Objective: To define whether there is any relation between the iron status of patients with hepatitis C virus (HCV) chronic liver disease anti their response to interferon therapy. Design: To evaluate the long-term response to 1 year of interferon therapy with addition of phlebotomies after 3 months of treatment if at that time alanine aminotransferase (ALT) had not normalized in a group of patients with HCV-positive chronic liver disease whose iron status had been characterized. Setting: A northern Italian hospital. Participants: Fifty-eight anti-HCV-positive patients (four HCV-RNA negative) with biopsy proven chronic hepatitis and no evidence of iron overload as indicated by normal transferrin saturation at the time of enrolment in the study. Intervention: Three times a week intramuscular injection of alpha interferon 3 MU for 1 year with addition of phlebotomies (350 ml/week) till iron depletion if after 3 months of interferon therapy ALT had not normalized. Results: A long-term response was observed in 19 of the 52 patients who completed the treatment, four HCV-RNA negative and 15 positive. The four RNA-negative and seven of the 15 RNA-positive long-term responders had been treated with interferon alone, and the other eight also with phlebotomies. At univariate analysis only HCV genotype, gamma-glutamyltranspeptidase and liver iron concentration were significantly associated with response whereas sinusoidal iron deposition was of borderline significance. No association was found with sex, age, duration of disease, histology, Knodell score, transferrin saturation %, serum ferritin, hepatocytic iron score, and portal iron score. HCV-RNA serum levels, measured in 29 patients, did not correlate with response. At multivariate analysis liver iron concentration was still significant and one unit reduction of liver iron concentration (natural logarithm transformed) was associated with 2.95 odds ratio of response. Conclusion: These results indicate that iron in the liver is more closely related to response to interferon than the other variables considered, including HCV characteristics.

KW - Cellular iron distribution

KW - Chronic hepatitis C

KW - Interferon

KW - Liver iron concentration

UR - http://www.scopus.com/inward/record.url?scp=8244248790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8244248790&partnerID=8YFLogxK

M3 - Article

C2 - 9187884

AN - SCOPUS:8244248790

VL - 9

SP - 497

EP - 503

JO - European Journal of Gastroenterology and Hepatology

JF - European Journal of Gastroenterology and Hepatology

SN - 0954-691X

IS - 5

ER -